Medindia

X

Laureate Pharma Elects New Board Member

Friday, September 18, 2009 General News J E 4
Advertisement


PRINCETON, N.J., Aug. 18 Laureate Pharma, Inc., a full-service biopharmaceutical development and protein production company, today announced the Election of Joel A. Tune as a new member of its Board of Directors.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080131/NETH020LOGO )

Along with providing expert guidance and strategic direction focused on Laureate's contract manufacturing business, Mr. Tune brings to Laureate more than 20 years of experience in P&L, strategy, operations, marketing and engineering leadership, in rapid-growth and transitional health products and service businesses. Throughout his career, he has worked in general management, sales and marketing, strategy, business development and engineering.

"Joel's exceptional mix of contract manufacturing expertise, in-depth knowledge of customer needs, and strong leadership skills will enable us to propel Laureate's growth and development and to achieve worldwide recognition for our fully-integrated contract development and bioprocessing services," said Robert J. Broeze, Ph.D., President & Chief Executive Officer of Laureate." As we continue to enhance the value proposition for our customers and to continue to build upon our momentum, we look to our new partnership with Joel to help aid in achieving our objectives for 2009 and beyond."

Mr. Tune most recently served as Vice President / General Manager, Global Drug Delivery of Baxter International where he transformed an established business, doubling revenues over five years to reach $800M+. Mr. Tune realigned the business model, products and market focus toward high value, rapidly expanding outsourcing services and technologies. He also successfully led a 14-member leadership team; 200 business development, sales and marketing, and product development professionals; over 800 employees in a dedicated facility; and effectively directed shared services production operations with 13 global manufacturing facilities. He concurrently, served on Baxter's senior management team with active involvement in cross-business communications, investor relations and industry outreach awareness. Previously, he was Vice President, Strategy & Business Development for Baxter and was responsible for in-house strategy and venture development. He orchestrated cross-divisional initiatives to create value within Baxter's largest product and distribution operations.

About Laureate Pharma

Laureate Pharma is a full-service biopharmaceutical development and protein production company located in Princeton, New Jersey. Laureate Pharma offers superior bioprocessing services that accelerate new products from development through production. Laureate provides a wide range of specialized services from process design and development to full-scale cGMP production, purification, aseptic filling, testing, validation, analytical services, and regulatory support. Laureate is focused on two active segments of the biopharmaceutical industry: monoclonal antibodies and recombinant protein products. For more information, contact Robert J. Broeze, Ph.D., President & CEO at (609) 919-3400, or info@laureatepharma.com or visit www.laureatepharma.com.

Available Topic Experts: For information on the listed experts, click appropriate link.

Robert Broeze

https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=84360

SOURCE Laureate Pharma, Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Inherited Risk Factors Increase Odds of Developing...
S
China Pharma Holdings, Inc. Announces SFDA Approva...